Detail akcie Scinai Sp ADR online

Business Summary: Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Scinai Immunotherapeutics Ltd - ADR revenues increased from $284K to $773K. Net loss increased 21% to $4.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions.